Decheng Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research.
BiotechDeep TechHealthtechMedical DevicesBoulder, US
John Foskett(Executive Officer, Director, Promoter)Brian Deneau(Chief Operating and Finance Officer)inStephen Picone(Chief Strategic Officer)inBrian Kudlow(Chief Scientific Officer)inTrey Foskett(Chief Executive Officer)inKerri Stellato(Chief Commercial Officer)in
Co-investorsEclipse Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.